Skip to main content

Table 5 Outcomes of neonates born after transferring embryo with or without blastomere loss, according to multiplicity

From: Outcomes of neonates born following transfers of frozen-thawed cleavage-stage embryos with blastomere loss: a prospective, multicenter, cohort study

 

Singleton delivery

Multiple deliveries

All deliveries

 

Intact embryo group (n = 2187)

Blastomere loss group (n = 332)

OR (95% CI)

aOR (95% CI)a

Intact embryo group (n = 1559)

Blastomere loss group (n = 151)

OR (95% CI)

aOR (95% CI)a

Intact embryo group (n = 3746)

Blastomere loss group (n = 483)

OR (95% CI)

aOR (95% CI)a

No. (%)

No. (%)

No. (%)

No. (%)

No. (%)

No. (%)

Gestational age, Mean (SD), years

38.13 (1.76)

38.33 (1.83)

  

35.78 (2.04)

36.09 (2.23)

  

37.14 (2.22)

37.63 (2.22)

  

Sex (Female)

1040 (47.6)

172 (51.8)

1.19 (0.94–1.49)

1.21 (0.95–1.55)

767 (49.2)

77 (51.0)

1.07 (0.77–1.50)

1.02 (0.72–1.44)

1807 (48.2)

249 (51.6)

1.14 (0.94–1.38)

1.13 (0.93–1.38)

Birthweight

            

  < 2500 g

115 (5.3)

20 (6.0)

1.16 (0.71–1.90)

1.42 (0.76–2.66)

757 (48.4)

81 (53.6)

1.23 (0.88–1.72)

1.07 (0.71–1.61)

870 (23.2)

101 (20.9)

0.89 (0.70–1.12)

0.87 (0.64–1.19)

  > 4000 g

219 (10.0)

35 (10.5)

1.07 (0.73–1.56)

1.08 (0.72–1.62)

1 (0.1)

0 (0.0)

NA

NA

220 (5.9)

35 (7.3)

1.22 (0.84–1.77)

1.28 (0.86–1.92)

Birthweight for gestational age

 SGA

65 (3.0)

16 (4.8)

1.61 (0.92–2.83)

1.84 (0.99–3.37)

285 (18.3)

41 (27.2)

1.64 (1.12–2.41)

1.50 (1.00–2.25)

350 (9.3)

57 (10.6)

1.29 (0.96–1.75)

1.14 (0.83–1.56)

 LGA

376 (17.2)

49 (14.8)

0.85 (0.62–1.18)

0.80 (0.57–1.13)

42 (2.7)

2 (1.3)

0.54 (0.13–2.28)

0.44 (0.10–1.90)

418 (11.2)

51 (11.8)

0.97 (0.71–1.32)

0.91 (0.66–1.26)

Apgar ≤ 7 (1 min)

30 (1.4)

7 (2.1)

1.55 (0.68–3.56)

2.52 (0.99–6.39)

43 (2.8)

5 (3.3)

1.21 (0.47–3.10)

1.80 (0.63–5.15)

73 (2.0)

12 (2.5)

1.28 (0.69–2.38)

1.39 (0.73–2.64)

Apgar ≤ 7 (5 min)

12 (0.6)

3 (0.9)

1.65 (0.46–5.88)

4.22 (0.97–18.44)

19 (1.2)

2 (1.3)

1.09 (0.25–4.73)

1.55 (0.29–8.26)

31 (0.8)

5 (1.0)

1.25 (0.48–3.24)

2.76 (0.94–8.13)

Neonatal respiratory distress

 TTN

13 (0.6)

6 (1.8)

3.07 (1.16–8.13)

6.27 (1.86–21.14)

33 (2.1)

8 (5.3)

2.60 (1.17–5.74)

5.21 (1.90–14.27)

46 (1.2)

14 (2.9)

2.38 (1.30–4.36)

5.21 (2.42–11.22)

 RDS

41 (1.9)

5 (1.5)

0.82 (0.32–2.08)

1.11 (0.38–3.29)

134 (8.6)

13 (8.6)

1.04 (0.57–1.89)

0.77 (0.37–1.60)

181 (4.7)

18 (3.7)

0.80 (0.49–1.32)

0.91 (0.49–1.67)

Congenital anomalyb

6 (0.3)

2 (0.6)

2.20 (0.44–10.96)

1.98 (0.35–11.17)

14 (0.9)

1 (0.7)

0.73 (0.10–5.65)

0.57 (0.06–5.17)

20 (0.5)

3 (0.6)

1.16 (0.34–3.94)

1.18 (0.32–4.31)

Neonatal mortality c

2 (0.1)

1 (0.3)

3.30 (0.30–36.50)

NA

6 (0.4)

0 (0.0)

NA

NA

8 (0.2)

1 (0.2)

0.97 (0.12–7.78)

1.36 (0.10–11.00)

  1. FET frozen-thawed embryo transfer, AGA appropriate for gestational age, SGA small for gestational age, LGA large for gestational age, TTN transient tachypnea of the newborn, RDS respiratory distress syndrome, HRT hormone replacement therapy, OR odds ratio, CI confidence interval, aOR adjusted odds ratio, NA not accessible
  2. aaOR was adjusted for gestational diabetes mellitus, hypertensive disorder, paternal smoking during pregnancy, number of previous abortion, primary infertility, preterm delivery, mode of delivery, and type of embryo cryopreservation
  3. bOf the 8 singletons who had congenital anomaly, 2 in the intact embryo group had congenital heart diseases, 2 in the intact embryo group had congenital preauricular fistula, and another 2 in the intact embryo group had congenital anal atresia and hypospadias. Two singletons in the blastomere loss group had hypospadias and cheilopalatognathus. Of the 14 multiples neonates, 7 in the intact embryo group had congenital heart diseases, 2 in the intact embryo group had congenital anal atresia, 2 in the intact embryo group had multiple anomalies, the rest in the intact embryo group had spina bifida, polydactyly, and tracheobronchial malacia, respectively. One multiples neonate in the blastomere loss group had congenital heart disease
  4. cOf the 3 neonatal deaths of singletons, 2 in the intact embryo group died due to respiratory distress and cerebral palsy, 1 in the blastomere loss group died due to neonatal encephalopathy. Of the 6 neonatal deaths of multiples neonates in the intact embryo group, 3 neonates died due to neonatal encephalopathy, another 3 each died due to tetralogy of Fallot, congenital anal atresia, and cerebral palsy
Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us